Onkar Bedi

发表

Mechanistic and physiological approaches of fecal microbiota transplantation in the management of NAFLD

T. G. Singh, P. Krishan, N. Trehanpati, 2021, Inflammation Research.

Shamsher Singh, Onkar Bedi, Ganesh Singh Bhakuni, 2017 .

Molecular and pathobiological involvement of fetuin-A in the pathogenesis of NAFLD

R. Goyal, Onkar Bedi, Ojus Sardana, 2021, Inflammopharmacology.

Histopathological and molecular links of COVID-19 with novel clinical manifestations for the management of coronavirus-like complications

Ankita Sood, Onkar Bedi, 2022, Inflammopharmacology.

Carbohydrate restriction ameliorates nephropathy by reducing oxidative stress and upregulating HIF-1α levels in type-1 diabetic rats

P. Krishan, Gaaminepreet Singh, Onkar Bedi, 2017, Journal of Diabetes & Metabolic Disorders.

Fatty acid synthase inhibition ameliorates diabetes induced liver injury in rodent experimental model.

P. Krishan, D. Parsad, Onkar Bedi, 2021, European journal of pharmacology.

THERAPEUTIC USES OF RICE BRAN AND ITS COMPONENTS

N. Kaur, M. Kaur, Harmanpreet Kaur, 2015 .

Proposed hypothesis of GSK-3 β inhibition for stimulating Wnt/β-catenin signaling pathway which triggers liver regeneration process

Onkar Bedi, Chirag Khurana, 2022, Naunyn-Schmiedeberg's Archives of Pharmacology.

Anti-hyperalgesic and anti-nociceptive potentials of standardized grape seed proanthocyanidin extract against CCI-induced neuropathic pain in rats

Puneet Kumar, R. Deshmukh, Shamsher Singh, 2016, Journal of basic and clinical physiology and pharmacology.

Animal models of hepatotoxicity

Puneet Kumar, R. Deshmukh, J. Bariwal, 2015, Inflammation Research.

INVESTIGATIONAL STUDY ON AWARENESS OF NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) AMONG PEOPLE OF ZIRAKPUR (PUNJAB) REGION

T. G. Singh, Manisha Gupta, S. Arora, 2019 .

Impact of diet restriction in the management of diabetes: evidences from preclinical studies

P. Krishan, Onkar Bedi, M. Rani, 2018, Naunyn-Schmiedeberg's Archives of Pharmacology.

Role of vitamins and minerals as immunity boosters in COVID-19

Puneet Kumar, Manisha Gupta, S. Sharma, 2021, Inflammopharmacology.

Investigations on acute oral toxicity studies of purpurin by application of OECD guideline 423 in rodents

P. Krishan, Onkar Bedi, 2019, Naunyn-Schmiedeberg's Archives of Pharmacology.

Herbal Induced Hepatoprotection and Hepatotoxicity: A Critical Review.

Puneet Kumar, V. Gauttam, K. R. Bijjem, 2016, Indian journal of physiology and pharmacology.

Animal models of hepatotoxicity

Puneet Kumar, R. Deshmukh, J. Bariwal, 2015, Inflammation Research.

In vitro targeted screening and molecular docking of stilbene, quinones, and flavonoid on 3T3-L1 pre-adipocytes for anti-adipogenic actions

A. S. Grewal, P. Krishan, N. Trehanpati, 2020, Naunyn-Schmiedeberg's Archives of Pharmacology.

Animal Models of Schizophrenia

Shamsher Singh, Sumit Jamwal, Onkar Bedi, 2017 .

Combined effect of hydrogen sulphide donor and losartan in experimental diabetic nephropathy in rats

Puneet Kumar, M. Kaur, Onkar Bedi, 2015, Journal of Diabetes & Metabolic Disorders.

Pathobiological and molecular connections involved in the high fructose and high fat diet induced diabetes associated nonalcoholic fatty liver disease

Ekta, T. G. Singh, Manisha Gupta, 2020, Inflammation Research.

Pleiotropic effects of statins: new therapeutic targets in drug design

Puneet Kumar, V. Dhawan, P. Sharma, 2016, Naunyn-Schmiedeberg's Archives of Pharmacology.

Rodent animal models: from mild to advanced stages of diabetic nephropathy

Puneet Kumar, M. Kaur, Onkar Bedi, 2014, Inflammopharmacology.

Role of Microbiota in Pathogenesis and Management of Viral Hepatitis

N. Trehanpati, Onkar Bedi, R. Sehgal, 2020, Frontiers in Cellular and Infection Microbiology.

A review: traditional herbs and remedies impacting pathogenesis of Parkinson’s disease

R. Deshmukh, Vishavdeep Sharma, Manisha Gupta, 2022, Naunyn-Schmiedeberg's Archives of Pharmacology.

Metabolomic analysis shows dysregulation in amino acid and NAD+ metabolism in palmitate treated hepatocytes and plasma of non-alcoholic fatty liver disease spectrum.

R. Maiwall, V. Pamecha, A. Rastogi, 2022, Biochemical and biophysical research communications.

POSSIBLE THERAPEUTIC POTENTIAL OF STATIN INDEPENDENT OF LIPID-LOWERING ACTIVITY

N. Soni, K. Reddy, Onkar Bedi, 2013 .

Impact of diet restriction in the management of diabetes: evidences from preclinical studies

P. Krishan, Onkar Bedi, M. Rani, 2017, Naunyn-Schmiedeberg's Archives of Pharmacology.

Molecular and Pathological Events Involved in the Pathogenesis of Diabetes-Associated Nonalcoholic Fatty Liver Disease.

P. Krishan, N. Trehanpati, G. Ramakrishna, 2019, Journal of clinical and experimental hepatology.

Pleiotropic effects of statins: new therapeutic targets in drug design

Puneet Kumar, V. Dhawan, Onkar Bedi, 2016, Naunyn-Schmiedeberg's Archives of Pharmacology.

Erratum to: Combined effect of hydrogen sulphide donor and losartan in experimental diabetic nephropathy in rats

Puneet Kumar, M. Kaur, Onkar Bedi, 2015, Journal of Diabetes & Metabolic Disorders.